Ikarian Capital’s Puma Biotechnology PBYI Stock Holding History

Ikarian Capital’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49,843	Closed	-$144K	–	196
2022 Q1	$144K	Hold	49,843	–	–	0.04%	174
2021 Q4	$152K	Hold	49,843	–	–	0.04%	165
2021 Q3	$349K	Sell	49,843 -5,058	-9%	-$37.9K	0.08%	193
2021 Q2	$504K	Hold	54,901	–	–	0.09%	187
2021 Q1	$533K	Hold	54,901	–	–	0.08%	256
2020 Q4	$563K	Hold	54,901	–	–	0.1%	188
2020 Q3	$554K	Hold	54,901	–	–	0.15%	140
2020 Q2	$573K	Hold	54,901	–	–	0.17%	130
2020 Q1	$463K	Sell	54,901 -256,352	-82%	-$2.49M	0.17%	135
2019 Q4	$2.72M	Buy	+311,253	New	+$2.58M	2.51%	56

Other funds holding PBYI

Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return